BROOMFIELD, Colo.--(BUSINESS WIRE)--Biodesix Inc., a fully integrated molecular diagnostic company dedicated to personalizing medicine, is pleased to be the recipient of Frost & Sullivan’s 2011 North American Cancer Diagnostics Product Differentiation Excellence Award.
